Q4 2024 IQVIA Holdings Inc Earnings Call Transcript
Key Points
- IQVIA Holdings Inc (IQV) reported strong revenue growth of 5.5% at constant currency for the full year 2024, excluding COVID-related work.
- The company achieved a record quarter of free cash flow, with a 41% increase year-over-year, totaling $2.1 billion.
- IQVIA Holdings Inc (IQV) successfully renewed all large pharma strategic partnerships and expanded the scope of work in several partnerships.
- The company introduced 60 innovations in 2024, including 39 AI-enabled applications, enhancing its technological capabilities.
- IQVIA Holdings Inc (IQV) was recognized with several awards, including the 2024 Global Customer Value Leadership Award for excellence in AI quality and regulatory solutions in healthcare.
- The company faced significant challenges in 2024 due to the Inflation Reduction Act, leading to delayed customer decision-making and reduced discretionary spending.
- IQVIA Holdings Inc (IQV) experienced a high level of cancellations, nearly 50% higher than the average of the previous three years.
- The R&D Solutions segment saw a decline in revenue, down 1.3% reported and 1% at constant currency for the fourth quarter.
- The company anticipates continued volatility in the R&D Solutions demand environment for the next one to two quarters.
- IQVIA Holdings Inc (IQV) faced foreign currency headwinds, impacting revenue growth and financial performance.
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA fourth quarter 2024 earnings conference call. All lines have been placed on mute to prevent any background noise. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the call over to Kerri Joseph, Senior Vice President, Investor Relations and Treasury. Mr. Joseph, you may now begin your conference.
Thank you, operator. Good morning, everyone. Thank you for joining our fourth quarter 2024 earnings call. With me today are Ari Bousbib, Chairman and Chief Executive Officer; Ron pBruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Gustavo Perrone, Senior Director, Investor Relations.
Today, we will be referencing a presentation that will be visible during this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

